AU462250B2 - Pharmaceutically active triazenomidazoles - Google Patents

Pharmaceutically active triazenomidazoles

Info

Publication number
AU462250B2
AU462250B2 AU47236/72A AU4723672A AU462250B2 AU 462250 B2 AU462250 B2 AU 462250B2 AU 47236/72 A AU47236/72 A AU 47236/72A AU 4723672 A AU4723672 A AU 4723672A AU 462250 B2 AU462250 B2 AU 462250B2
Authority
AU
Australia
Prior art keywords
triazenomidazoles
pharmaceutically active
pharmaceutically
active
active triazenomidazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU47236/72A
Other versions
AU4723672A (en
Inventor
HEYES and NEAL WARD JAMES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU4723672A publication Critical patent/AU4723672A/en
Application granted granted Critical
Publication of AU462250B2 publication Critical patent/AU462250B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47236/72A 1971-09-29 1972-09-28 Pharmaceutically active triazenomidazoles Expired AU462250B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4530971A GB1373347A (en) 1971-09-29 1971-09-29 Triazenoimidazoles
GBGB45309/71 1971-09-29

Publications (2)

Publication Number Publication Date
AU4723672A AU4723672A (en) 1974-04-04
AU462250B2 true AU462250B2 (en) 1975-06-19

Family

ID=10436729

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47236/72A Expired AU462250B2 (en) 1971-09-29 1972-09-28 Pharmaceutically active triazenomidazoles

Country Status (9)

Country Link
JP (1) JPS5529991B2 (en)
AU (1) AU462250B2 (en)
BE (1) BE789102A (en)
DE (1) DE2247065A1 (en)
FR (1) FR2154566B1 (en)
GB (1) GB1373347A (en)
IL (1) IL40353A0 (en)
NL (1) NL7212596A (en)
ZA (1) ZA726195B (en)

Also Published As

Publication number Publication date
JPS5529991B2 (en) 1980-08-07
IL40353A0 (en) 1972-11-28
BE789102A (en) 1973-03-21
FR2154566B1 (en) 1976-04-23
JPS4840768A (en) 1973-06-15
FR2154566A1 (en) 1973-05-11
NL7212596A (en) 1973-04-02
DE2247065A1 (en) 1973-04-05
AU4723672A (en) 1974-04-04
ZA726195B (en) 1973-06-27
GB1373347A (en) 1974-11-13

Similar Documents

Publication Publication Date Title
CA949967A (en) Pharmacologically active compounds
CA997852A (en) Headsets
CA955513A (en) Chair
CA987578A (en) Chair
AU463756B2 (en) Combine
AU4297272A (en) Chair
PH12247A (en) Pharmaceutically active compounds
CA974134A (en) Polyamide-metal structure
CA1024152A (en) Surface active compounds
AU2440371A (en) Pharmaceutically active substituted pyrrolidines
CA983684A (en) Superconductors
CA975004A (en) Anti-microbially active surface-active compounds
CA938738A (en) Superconductors
PH9441A (en) Pharmacologically active pyridazinyl-isoindolin-1-one derivatives
AU462250B2 (en) Pharmaceutically active triazenomidazoles
CA884283A (en) Therapeutically active compounds
CA865120A (en) Therapeutically active compounds
AU2587871A (en) Medicament
AU481531B2 (en) Therapeutically active aryldiamides
AU454787B2 (en) Surface active agents
CA883859A (en) Surface active agents
CA886037A (en) Therapeutic agents
CA883504A (en) Structures
AU5203473A (en) Therapeutically active aryldiamides
CA865130A (en) Chemotherapeutical agents